Science Translational Medicine · 2019 · 87 citations · 40 references
MedicineNeurosciencePharmacologyMemoryNeuroplasticityLearning In AnimalsLearning-related PlasticityMemory ConsolidationNeural PlasticityNeurodevelopmental DisordersFragile X Syndrome ModelsLong-term Memory ConsolidationMemory DysfunctionRodent LearningSpatial Memory DeficitsTreatment-related Neurocognitive EffectsX-linked Neurodevelopmental Disorders
KO rats with lovastatin between 5 and 9 weeks of age, during the normal developmental period that this associative memory capability is established, prevents the emergence of deficits but has no effect in wild-type animals. Moreover, we observe no regression of cognitive performance in the FXS rats over several months after treatment. This restoration of the normal developmental trajectory of cognitive function is associated with the sustained rescue of both synaptic plasticity and altered protein synthesis. The findings provide proof of concept that the impaired emergence of the cognitive repertoire in neurodevelopmental disorders may be prevented by brief, early pharmacological intervention.
40
Fitting Linear Mixed-Effects Models Using <b>lme4</b>
Douglas M. Bates, Martin Mächler, Benjamin M. Bolker et al. · Journal of Statistical Software · 2015 · 85.6K citations · Full text